Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Online therapy for managing pain in fibromyalgia and lupus patients

Official title: Brief Pain Exposure Therapy (BPET) For Nociplastic Pain

Run by University of Michigan · NCT06208514 · Data updated 2026-11-12

This study is testing an online therapy called Brief Pain Exposure Therapy to see if it can help adults with fibromyalgia and lupus manage their pain and improve their overall well-being.

More Fibromyalgia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment125 (estimated)
SponsorUniversity of Michigan
Academic / other
Drugs / interventionsprednisone
Locations1 site (Ann Arbor, Michigan)
StatusRecruiting
StartedMarch 4, 2024
Main results expectedApril 2027
Study endsJuly 2027
Registry record updatedMay 11, 2026
Trial IDNCT06208514 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults diagnosed with fibromyalgia or systemic lupus erythematosus who have access to the internet and can participate in Zoom meetings.

Probably not a fit

Patients who do not have a diagnosis of fibromyalgia or lupus, or those unable to participate in telehealth sessions, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a brief, Zoom-based behavioral treatment called Brief Pain Exposure Therapy (BPET) aimed at helping adults with fibromyalgia and systemic lupus erythematosus. Participants will learn effective strategies to reduce pain and associated issues such as disability, depression, and anxiety. The study is conducted by the University of Michigan and includes specific eligibility criteria for participants based on their medical diagnoses and pain experiences.

Why it matters

Potential benefit: If successful, this therapy could provide patients with effective tools to manage their pain and improve their quality of life.

How similar studies have gone: Other studies have shown promise in using telehealth-based behavioral interventions for pain management, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Able to read, write and speak English
* Internet access and audio-visual conferencing capability (e.g., Zoom meetings by phone or computer) in the home

Fibromyalgia participants must have:

* Physician diagnosis of fibromyalgia
* OR: meet 2016 American College of Rheumatology (ACR) Criteria for FM: Widespread pain index score is ≥ 7 and symptom severity scale score is ≥ 5, or widespread pain index score is 4 to 6 and symptom severity score is ≥ 9
* OR: have pain self-reported in 4 out of 7 body regions in the General Sensory Sensitivity (GSS)-brief body map AND Opioid Use Disorder diagnosis by a physician.

Lupus participants must have:

* Physician diagnosis of systemic lupus erythematosus
* AND: Have pain self-reported in 4 out of 7 body regions in the GSS-brief body map
* AND: No change in medications or steroid dose for one month prior to entry (to avoid oscillation of steroid dosing during the study due to active disease).

Chronic Low Back Pain participants must have:

* Low Back Pain for at least half the days over the past 6 months
* Over the past 7 days, an average pain intensity of at least 4 out of 10

Exclusion Criteria:

* Indication of a co-occurring (non-fibromyalgia OR non-lupus) cause of chronic pain (e.g., inflammatory arthritis, other autoimmune disorders, spinal cord injury, cancer)
* Currently receiving cognitive-behavioral therapy or other psychological therapies for pain
* Open litigation regarding chronic pain in the past 1 year, as assessed in preliminary study screening.
* Inability to provide informed consent and complete study procedures (e.g., indications of suspected major cognitive impairment via observations of study staff during consenting) that would preclude comprehension or participation in study protocols.
* Pregnant or breastfeeding
* Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.
* Lupus group only: taking \>10 mg prednisone (or equivalent steroid) dose per day as an indicator of ongoing disease activity (with no other strict exclusions based on medications)
* Chronic Pelvic Pain group only: surgery for any chronic pelvic pain related condition in the past 6 months
* Chronic low back pain only: scheduled back surgery; leg pain that is greater than your back pain

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.